How GSK’s Canada SC hearing unfolded
The Supreme Court of Canada met in January to hear the Canada Revenue Agency's (CRA) appeal and GlaxoSmithKline's (GSK) response in a case about whether the taxpayer paid too much for active pharmaceutical ingredients (API) from a Swiss associated enterprise.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: